San Diego, CA -- (SBWIRE) -- 05/11/2015 -- An investigation on behalf of investors of IGI Laboratories, Inc. (NYSEMKT:IG) shares over potential securities laws violations by IGI Laboratories and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of IGI Laboratories, Inc. (NYSEMKT:IG) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of IGI Laboratories, Inc. (NYSEMKT:IG) concerning whether a series of statements by IGI Laboratories, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

IGI Laboratories, Inc. reported that its annual Total Revenue rose from $8.56 million in 2012 to $33.74 million in 2014 and that its Net Loss of $3.93 million in 2012 turned into a Net Income of $5.25 million in 2014. Shares of IGI Laboratories, Inc. (NYSEMKT:IG) grew from $1.04 per share in early 2013 to as high as $11.52 per share in February 2015.

On April 28, 2015, IGI Laboratories, Inc. announced its first quarter 2015 results. Shares of IGI Laboratories, Inc. (NYSEMKT:IG) declined to as low as $4.75 per share on May 1, 2015.

Those who purchased shares of IGI Laboratories, Inc. (NYSEMKT:IG) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com